[HTML][HTML] Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: results from the randomized BFORE trial

JE Cortes, C Gambacorti-Passerini… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
Purpose Bosutinib is a potent dual SRC/ABL kinase inhibitor approved for adults with
Philadelphia chromosome–positive chronic myeloid leukemia (CML) resistant and/or …

The use of light‐emitting diode therapy in the treatment of photoaged skin

F Baez, LR Reilly - Journal of cosmetic dermatology, 2007 - Wiley Online Library
Background Light‐emitting diode (LED) therapy is an increasingly popular methodology for
the treatment of sun damage. Combination use of light wavelengths reported to stimulate …

Combined 633-nm and 830-nm led treatment of photoaging skin.

DJ Goldberg, S Amin, BA Russell, R Phelps… - Journal of drugs in …, 2006 - europepmc.org
Objectives To evaluate the clinical efficacy and ultrastructural changes in photodamaged
skin after combined 633-nm and 830-nm light-emitting diode (LED) treatments. Methods …

Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE study

C LaForce, BE Chipps, FC Albers, L Reilly… - Annals of Allergy …, 2022 - Elsevier
Background PT027 is a fixed-dose combination of albuterol (salbutamol) and budesonide in
a single pressurized metered-dose inhaler. Objective To evaluate the efficacy and safety of …

Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged≥ 4 years with moderate-to-severe asthma: rationale and design of …

BE Chipps, FC Albers, L Reilly… - BMJ Open …, 2021 - bmjopenrespres.bmj.com
Introduction Uncontrolled asthma is associated with substantial morbidity. While fast-acting
bronchodilators provide quick relief from asthma symptoms, their use as rescue fails to …

Applying nurture as a whole school approach.

S McNicol, L Reilly - Educational and Child Psychology, 2018 - psycnet.apa.org
Aims: Applying Nurture as a Whole School Approach (ANWSA)(Education Scotland, 2016a),
supports practitioners to evaluate the implementation of whole establishment nurture …

Angiotensin converting enzyme inhibitors. 9. Novel [[N-(1-carboxyl-3-phenylpropyl) amino] acyl] glycine derivatives with diuretic activity

JN Barton, JJ Piwinski, JW Skiles… - Journal of medicinal …, 1990 - ACS Publications
A series of molecules 1 having sulfonamide diuretic moieties covalently linked to non-
sulfhydryl angiotensin-converting enzyme inhibitors (ACEI) were prepared and tested for …

Bosutinib (BOS) versus imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE trial.

JE Cortes, C Gambacorti-Passerini, MWN Deininger… - 2017 - ascopubs.org
7002 Background: BOS is a potent, dual SRC/ABL tyrosine kinase inhibitor approved for
treatment (tx) of adults with Ph+ CML resistant/intolerant to prior therapy. We assessed the …

A CONVENIENT N-ACETYLATION OF INDOLES

GW Gribble, LW Reilly Jr… - Organic Preparations and …, 1977 - Taylor & Francis
II 1 CH3 This method provides a very attractive alternative to earlier indole acylation
methodsY2 some of which give a mixture of N-and C-acylation product, and to the more …

Sensory process instruction with learning disabled children

JF Curley, LJ Reilly - Perceptual and motor skills, 1983 - journals.sagepub.com
To determine whether the use of a teaching method geared to an individual learner's
dominant perceptual modality would increase level of learning and the efficiency with which …